STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.

$15.89  +0.22 (1.37%)
As of 06/28/2022 13:59:23 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Pharmaceutical Retailers
Index country:  Italy
Country of incorporation:  
IPO date:  07/16/2021
Outstanding shares:  295,540,036
Average volume:  312,355
Market cap:   $4,770,016,181
Current dividend yield:  0.32%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BNM0752

---

Valuation   (See tab for details)

---

PE ratio:   36.90
PB ratio:   4.69
PS ratio:   5.24
Return on equity:   14.18%
Net income %:   14.54%